Back to Search
Start Over
Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation.
- Source :
-
Clinical Case Reports . Sep2021, Vol. 9 Issue 9, p1-4. 4p. - Publication Year :
- 2021
-
Abstract
- Although ruxolitinib contributes to immunomodulation and can lead to severe infections, it seems a feasible treatment strategy for patients with polycythemia vera and myelofibrosis after liver transplantation. [ABSTRACT FROM AUTHOR]
- Subjects :
- *POLYCYTHEMIA vera
*RUXOLITINIB
*LIVER transplantation
*MYELOFIBROSIS
*THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 20500904
- Volume :
- 9
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Clinical Case Reports
- Publication Type :
- Academic Journal
- Accession number :
- 152653659
- Full Text :
- https://doi.org/10.1002/ccr3.4782